Lexicon cuts about 75 sales jobs to prep for drug launch early next year
Ahead of an FDA decision date later this year, Lexicon Pharmaceuticals is trimming its workforce.
The company will lay off roughly half of its sales …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
